[陳志豪] 專利 |
2014-03-11 |
脯胺酸衍生物 |
- |
|
[陳志豪] 專利 |
2010-08-21 |
硫尿化合物及抑制C型肝炎病毒感染之方法 |
- |
|
[夏克山] 專利 |
2011-10-01 |
硒吩化合物及其醫藥組成物 |
- |
|
[謝奉勳] 專利 |
2014-09-01 |
治療阿茲海默症或帕金森氏症之醫藥組成物 |
- |
|
[謝興邦] 專利 |
2013-11-21 |
治療癌症的醫藥組成物 |
- |
|
[岳嶽] 專利 |
2015-06-01 |
治療C型肝炎病毒感染之醫藥組成物 |
- |
|
[謝興邦] 專利 |
2008-05-01 |
抗腫瘤化合物 |
- |
|
[謝興邦] 專利 |
2010-12-01 |
抗肿瘤化合物 |
- |
|
[葉燈光] 專利 |
2013-02-11 |
抗癌口服藥學組成物 |
- |
|
[葉燈光] 專利 |
2014-06-04 |
抗癌口服制剂 |
- |
|
[徐祖安] 專利 |
2011-06-21 |
抑制冠狀病毒之醫藥組合物 |
- |
|
[徐祖安] 專利 |
2011-06-21 |
抑制冠狀病毒之醫藥組合物 |
- |
|
[徐祖安] 專利 |
2011-06-21 |
抑制冠狀病毒之醫藥組合物 |
- |
|
[夏克山] 專利 |
2013-09-11 |
噻吩化合物及其醫藥組成物 |
- |
|
[夏克山] 專利 |
2012-07-04 |
噻吩化合物 |
- |
|
[夏克山] 專利 |
2011-08-11 |
噁二唑化合物 |
- |
|
[謝興邦] 專利 |
2013-10-01 |
喹啉化合物及包含其之治療病毒感染之醫藥組成物 |
- |
|
[陳志豪] 專利 |
2012-04-11 |
咪唑啉酮及咪唑啉硫酮衍生物 |
- |
|
[夏克山] 專利 |
2014-04-21 |
咪唑-4-酮及咪唑-4-硫酮化合物 |
- |
|
[夏克山] 專利 |
2014-11-19 |
咪唑-4-酮及咪唑-4-硫酮化合物 |
- |
|
[謝興邦] 專利 |
2010-12-01 |
吲哚化合物 |
- |
|
[謝興邦] 專利 |
2008-12-11 |
吲哚化合物 |
- |
|
[夏克山] 專利 |
2015-02-11 |
吡唑類化合物 |
- |
|
[夏克山] 專利 |
2011-03-21 |
吡唑化合物及其醫藥組成物 |
- |
|
[蔣維棠] 專利 |
2013-12-18 |
吡咯烷化合物 |
- |
|
[蔣維棠] 專利 |
2010-10-06 |
吡咯烷化合物 |
- |
|
[蔣維棠] 專利 |
2013-02-11 |
吡咯啉啶化合物 |
- |
|
[蔣維棠] 專利 |
2012-04-21 |
吡咯啉啶化合物 |
- |
|
[蔣維棠] 專利 |
2008-07-21 |
吡咯啉啶化合物 |
- |
|
[謝興邦] 專利 |
2014-10-21 |
化合物於製造治療病毒感染的藥物之用途 |
- |
|
[謝興邦] 專利 |
2013-07-01 |
做為蛋白質激酶抑制劑之稠合多環化合物 |
- |
|
[謝興邦] 專利 |
2013-02-11 |
作為酪胺酸激酶抑制劑之稠合雙環及多環嘧啶化合物 |
- |
|
[蔣維棠] 專利 |
2014-04-21 |
作為蛋白質激酶抑制劑之吡唑化合物及噻唑化合物、其醫藥組成物及用途 |
- |
|
[謝興邦] 專利 |
2015-07-31 |
作為極光激酶抑制劑的稠合雙環嘧啶化合物 |
- |
|
[謝興邦] 專利 |
2014-10-29 |
作為極光激酶抑制劑的稠合雙環嘧啶化合物 |
- |
|
[謝興邦] 專利 |
2012-05-11 |
作為極光激酶抑制劑之稠合雙環嘧啶化合物 |
- |
|
[謝興邦] 專利 |
2015-07-22 |
作为酪胺酸激酶抑制剂的稠合双环及多环嘧啶化合物 |
- |
|
[李秀珠] 專利 |
2014-05-11 |
二苯並〔f,h〕異喹啉衍生物及其醫藥組成物 |
- |
|
[李秀珠] 會議論文/會議摘要 |
2013-04 |
Tylophorine induces c-Jun protein accumulation through two discrete prolonged pathways NF-kappaB/PKCdelta/JNK and PI3K/PDK1/PP2A/eEF2 to promote G1 arrest in carcinoma cells |
- |
|
[李秀珠] 期刊論文 |
2009-08-14 |
Tylophorine arrests carcinoma cells at G1 phase by downregulating cyclin A2 expression |
- |
|
[謝奉勳] 專利 |
2012-06-12 |
Treatment of neurodegenerative disorders with thiourea compounds |
- |
|
[徐祖安] 專利 |
2009-06-09 |
Treatment of coronavirus infection |
- |
|
[陳志豪] 專利 |
2011-03-01 |
Thiourea derivatives |
- |
|
[夏克山] 專利 |
2013-03-27 |
Thiophene compounds |
- |
|
[夏克山] 專利 |
2010-11-16 |
Thiophene compounds |
- |
|
[翁紹華] 期刊論文 |
2019-04-01 |
The in vivo antinociceptive and mu-opioid receptor activating effects of the combination of N-phenyl-2′,4′-dimethyl-4,5′-bi-1,3-thiazol-2-amines and naloxone |
- |
|
[李靜琪] 期刊論文 |
2011-07-25 |
The first total synthesis of cytopiloyne, an anti-diabetic, polyacetylenic glucoside |
- |
|
[李秀珠] 期刊論文 |
2017-06-22 |
Targeting coronaviral replication and cellular JAK2 mediated dominant NF-kappaB activation for comprehensive and ultimate inhibition of coronaviral activity |
- |
|
[蔣維棠] 期刊論文 |
2011-02 |
Synthesis of 3,3-dimethylglutamic acid derivatives as DPP-IV inhibitors and evaluation of their chemical stability |
- |
|
[葉燈光] 期刊論文 |
2012-12-13 |
Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: Exploration of the role of tylophorine e ring on biological activity |
- |
|
[李靜琪] 期刊論文 |
2019-03 |
Synthesis and biological evaluation of N-glucosyl indole derivatives as sodium-dependent glucose co-transporter 2 inhibitors |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2012-02 |
Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents |
- |
|
[陳炯東] 期刊論文 |
2010-03 |
Synthesis and biological activities of 2-Amino-1-arylidenamino imidazoles as orally active anticancer agents |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2010-09-01 |
Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2011-03 |
Successful propagation of flavivirus infectious cDNAs by a novel method to reduce the cryptic bacterial promoter activity of virus genomes |
- |
|
[蔣維棠] 期刊論文 |
2006-06-15 |
Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2010-08 |
Substituted 4-carboxymethylpyroglutamic acid diamides as potent and selective inhibitors of fibroblast activation protein |
- |
|
[謝興邦] 期刊論文 |
2009-02-26 |
Structure-based drug design of novel aurora kinase a inhibitors: Structural basis for potency and specificity |
- |
|
[伍素瑩] 期刊論文 |
2006-05-04 |
Structure-based drug design of a novel family of PPAR gamma partial agonists: Virtual screening, X-ray crystallography, and in vitro/in vivo biological activities |
- |
|
[伍素瑩] 期刊論文 |
2006-08-24 |
Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease |
- |
|
[謝興邦] 期刊論文 |
2006-10-19 |
Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2010-10 |
Structural basis for the improved potency of peroxisome proliferator-activated receptor (PPAR) agonists |
- |
|
[夏克山] 專利 |
2010-09-28 |
Selenophene compounds |
- |
|
[翁紹華] 期刊論文 |
2022-11 |
Selective and antagonist-dependent µ-opioid receptor activation by the combination of 2-{[2-(6-chloro-3,4-dihydro-1(2H)-quinolinyl)-2-oxoethyl]sulfanyl}-5-phenyl-4,6-(1H,5H)-pyrimidinedione and naloxone/naltrexone |
- |
|
[岳嶽] 期刊論文 |
2013-02 |
Resistance studies of a di-thiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems |
- |
|
[岳嶽] 期刊論文 |
2012-01 |
Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor |
- |
|
[蔣維棠] 期刊論文 |
2009-04-01 |
Rational design and synthesis of potent and long-lasting glutamic acid-based dipeptidyl peptidase IV inhibitors |
- |
|
[葉燈光] 期刊論文 |
2007-10-01 |
Rapid and sensitive determination of fentanyl in dog plasma by on-line solid-phase extraction integrated with a hydrophilic column coupled to tandem mass spectrometry |
- |
|
[謝興邦] 專利 |
2014-04-29 |
Quinoline compounds and their use for treating viral infection |
- |
|
[蔣維棠] 專利 |
2011-05-25 |
Pyrrolidine derivatives |
- |
|
[蔣維棠] 專利 |
2013-04-30 |
Pyrrolidine derivatives |
- |
|
[蔣維棠] 專利 |
2013-09-27 |
Pyrrolidine derivatives |
- |
|
[蔣維棠] 專利 |
2012-06-15 |
Pyrrolidine derivatives |
- |
|
[蔣維棠] 專利 |
2014-08-01 |
Pyrrolidine derivatives |
- |
|
[蔣維棠] 專利 |
2014-02-19 |
Pyrrolidine derivatives |
- |
|
[蔣維棠] 專利 |
2014-05-12 |
Pyrrolidine derivatives |
- |
|
[蔣維棠] 專利 |
2014-04-25 |
Pyrrolidine derivatives |
- |
|
[蔣維棠] 專利 |
2014-05-08 |
Pyrrolidine derivatives |
- |
|
[蔣維棠] 專利 |
2011-09-20 |
Pyrrolidine derivatives |
- |
|
[蔣維棠] 專利 |
2012-01-17 |
Pyrrolidine compounds |
- |
|
[蔣維棠] 專利 |
2008-07-01 |
Pyrrolidine compounds |
- |
|
[趙宇生(2002-2013)] 專利 |
2009-01-22 |
Pyrrolidine compounds |
- |
|
[蔣維棠] 專利 |
2008-09-16 |
Pyrrolidine compounds |
- |
|
[蔣維棠] 專利 |
2010-03-30 |
Pyrrolidine compounds |
- |
|
[夏克山] 專利 |
2015-02-24 |
Pyrazole compounds |
- |
|
[夏克山] 專利 |
2014-07-30 |
Pyrazole compounds |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2010-02-23 |
Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity |
- |
|
[陳炯東] 期刊論文 |
2012-09 |
Putative tumor metastasis-associated genes in human gastric cancer |
- |
|
[徐祖安] 期刊論文 |
2013-05 |
Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: The role of the DFG motif in the design of epidermal growth factor receptor inhibitors |
- |
|
[謝興邦] 會議論文/會議摘要 |
2005-03 |
Promazine analogues as potential anti SARS-CoV drugs |
- |
|
[陳志豪] 專利 |
2015-05-29 |
Proline derivatives |
- |
|
[陳志豪] 專利 |
2013-04-09 |
Proline derivatives |
- |
|
[翁紹華] 期刊論文 |
2016-01 |
Phenyl benzenesulfonylhydrazides exhibit selective Indoleamine 2,3-Dioxygenase inhibition with potent in vivo pharmacodynamic activity and antitumor efficacy |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2015-07 |
Pharmacological induction of human fetal globin gene in hydroxyurea-resistant primary adult erythroid cells |
- |
|
[夏克山] 專利 |
2010-04-27 |
Oxadiazole compounds |
- |
|
[謝興邦] 期刊論文 |
2013-06-28 |
Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine aurora kinase inhibitor |
- |
|
[蔣維棠] 期刊論文 |
2009-03-15 |
Novel trans-2-aryl-cyclopropylamine analogues as potent and selective dipeptidyl peptidase IV inhibitors |
- |
|
[李秀珠] 期刊論文 |
2007-11 |
Novel small-molecule inhibitors of transmissible gastroenteritis virus |
- |
|
[謝興邦] 期刊論文 |
2005-12-29 |
Novel indole-based peroxisome proliferator-activated receptor agonists: Design, SAR, structural biology, and biological activities |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2011-01 |
Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay |
- |
|
[李靜琪] 期刊論文 |
2016-05 |
N-Indolylglycosides bearing modifications at the glucose C6-Position as Sodium-Dependent Glucose Co-transporter 2 inhibitors |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2004-09 |
Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone |
- |
|
[葉修華] 期刊論文 |
2014-12-01 |
Morphine drives internal ribosome entry site-mediated hnRNP K translation in neurons through opioid receptor-dependent signaling |
- |
|
[謝興邦] 會議論文/會議摘要 |
2010-08 |
Lead optimization of furanopyrimidine Aurora kinase inhibitors: Development of in vivo active agents in tumor xenograft models |
- |
|
[李秀珠] 期刊論文 |
2011-11 |
Isolation and biological activities of phenanthroindolizidine and septicine alkaloids from the formosan tylophora ovata |
- |
|
[徐祖安] 期刊論文 |
2011-04 |
Isatin-beta-thiosemicarbazones as potent herpes simplex virus inhibitors |
- |
|
[徐祖安] 期刊論文 |
2004-07 |
Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide |
- |
|
[謝興邦] 期刊論文 |
2011-09 |
Inhibition of HIV-1 Tat-mediated transcription by a coumarin derivative, BPRHIV001, through the Akt pathway |
- |
|
[洪明秀] 期刊論文 |
2012-07 |
Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors |
- |
|
[謝興邦] 專利 |
2008-11-11 |
Indole compounds |
- |
|
[謝興邦] 期刊論文 |
2006-02-09 |
Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: Design, synthesis, structural biology, and molecular docking studies |
- |
|
[陳志豪] 專利 |
2011-05-10 |
Imidazolidinone and imidazolidinethione derivatives |
- |
|
[夏克山] 專利 |
2013-01-15 |
Imidazol-4-one and imidazole-4-thione compounds |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2010-11 |
Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus |
- |
|
[李秀珠] 會議論文/會議摘要 |
2007-04-18 |
Identification of novel small-molecule inhibitors of transmissible gastroenteritis virus |
- |
|
[李秀珠] 會議論文/會議摘要 |
2013-04 |
Identification of a quinone compound inhibits human glutaminase activity and induces autophagy in carcinoma cells |
- |
|
[蔣維棠] 期刊論文 |
2015-07 |
Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations |
- |
|
[李靜琪] 期刊論文 |
2018-01-01 |
Identification of an oxime-containing C-glucosylarene as a potential inhibitor of sodium-dependent glucose co-transporter 2 |
- |
|
[謝興邦] 期刊論文 |
2010-02-01 |
Identification, SAR studies, and X-ray Co-crystallographic analysis of a novel furanopyrimidine aurora kinase a inhibitor |
- |
|
[夏克山] 期刊論文 |
2011-06 |
Hot topic: Opportunities and potential challenges for the treatment of metabolic syndrome |
- |
|
[徐祖安] 專利 |
2011-07-26 |
Hepatitis C virus inhibitors |
- |
|
[李靜琪] 專利 |
2014-04-15 |
Glycoside compounds |
- |
|
[伍素瑩] 期刊論文 |
2009-07-23 |
Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity |
- |
|
[謝興邦] 專利 |
2015-04-14 |
Fused multicyclic compounds as protein kinase inhibitors |
- |
|
[謝興邦] 專利 |
2013-08-21 |
Fused multicyclic compounds as protein kinase inhibitors |
- |
|
[謝興邦] 專利 |
2014-03-20 |
Fused bicyclic pyrimidine compounds as aurora kinase inhibitors |
- |
|
[謝興邦] 專利 |
2012-03-20 |
Fused bicyclic pyrimidine compounds as aurora kinase inhibitors |
- |
|
[謝興邦] 專利 |
2013-08-13 |
Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors |
- |
|
[葉燈光] 專利 |
2011-09-27 |
Formulations of indol-3-yl-2-oxoacetamide compounds |
- |
|
[謝興邦] 會議論文/會議摘要 |
2009-09 |
Fast-forwarding kinase drug discovery: aurora and EGFR kinase inhibitor lead development |
- |
|
[謝興邦] 期刊論文 |
2010-06-15 |
Fast-forwarding hit to lead: Aurora and epidermal growth factor receptor kinase inhibitor lead identification |
- |
|
[李秀珠] 會議論文/會議摘要 |
2013-04-13 |
Exploration of the role of tylophorine E ring in anti-Coronavirus activity-Tylophorine derived dibenzoquinolines impart multi-biological activities as orally active agents |
- |
|
[徐祖安] 期刊論文 |
2014-01-08 |
Evaluation of the antitumor effects of BPR1J-340, a potent and selective FLT3 inhibitor, alone or in combination with an HDAC inhibitor, vorinostat, in AML cancer |
- |
|
[黃嘯谷] 期刊論文 |
2013-09-11 |
Environmental alkylphenols modulate cytokine expression in plasmacytoid dendritic cells |
- |
|
[陳炯東] 期刊論文 |
2008-07-09 |
Enhanced oral bioavailability of paclitaxel by D-alpha-tocopheryl polyethylene glycol 400 succinate in mice |
- |
|
[徐祖安] 期刊論文 |
2012-06 |
EGFR and myosin II inhibitors cooperate to suppress EGFR-T790M-mutant NSCLC cells |
- |
|
[李秀珠] 期刊論文 |
2014-08 |
Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells |
- |
|
[夏克山] 期刊論文 |
2012-02 |
Discovery of novel stem cell mobilizers that target the CXCR4 receptor |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2011-01-13 |
Discovery of novel N -Beta- d -Xylosylindole derivatives as sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the management of hyperglycemia in diabetes |
- |
|
[陳炯東] 期刊論文 |
2010-12 |
Discovery of non-glycoside sodium-dependent glucose Co-transporter 2 (SGLT2) inhibitors by ligand-based virtual screening |
- |
|
[伍素瑩] 期刊論文 |
2006-06-15 |
Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies |
- |
|
[蔣維棠] 期刊論文 |
2013-06 |
Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3) |
- |
|
[夏克山] 期刊論文 |
2009-07-23 |
Discovery of 2-[5-(4-chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-ethyl-1H-pyrazol-3-yl]-1,5,5-trimethyl-1,5-dihydro-imidazol-4-thione (BPR-890) via an active metabolite. A novel, potent and selective cannabinoid-1 receptor inverse agonist with high antiobesity efficacy in DIO mice |
- |
|
[夏克山] 期刊論文 |
2013-11-13 |
Discovery of 1-(2,4-Dichlorophenyl)-N-(piperidin-1-yl)-4-((pyrrolidine-1-sulfonamido)methyl)-5 -(5-((4-(trifluoromethyl)phenyl)ethynyl)thiophene-2-yl)-1H-pyrazole-3-carboxamide as a novel peripherally restricted cannabinoid-1 receptor antagonist with significant weight-loss efficacy in diet-induced obese mice |
- |
|
[夏克山] 期刊論文 |
2010-09 |
Discovery of 1-(2,4-Dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophe n-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide as a potential peripheral cannabinoid-1 receptor inverse agonist |
- |
|
[翁紹華] 期刊論文 |
2014-08 |
Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors |
- |
|
[蔣維棠] 期刊論文 |
2011-07 |
Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3) |
- |
|
[翁紹華] 期刊論文 |
2014-09 |
Discovery, structure-activity relationship studies, and anti-nociceptive effects of 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one as novel opioid receptor agonists |
- |
|
[李秀珠] 專利 |
2013-07-16 |
Dibenzo[f,h]isoquinoline derivatives |
- |
|
[謝興邦] 會議論文/會議摘要 |
2013-04-07 |
Development drug candidate targeting EGFR kinase: DBPR112 |
- |
|
[謝興邦] 期刊論文 |
2007-02-01 |
Development and validation of a liquid chromatography-tandem mass spectrometry for the determination of BPR0L075, a novel antimicrotuble agent, in rat plasma: Application to a pharmacokinetic study |
- |
|
[李靜琪] 期刊論文 |
2015-07 |
Development and application of a fluorescent glucose uptake assay for the high-throughput screening of non-glycoside SGLT2 inhibitors |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2010-10-28 |
Design and synthesis of tetrahydropyridothieno[2,3-d]pyrimidine scaffold based epidermal growth factor receptor (EGFR) kinase inhibitors: the role of side chain chirality and michael acceptor group for maximal potency |
- |
|
[謝興邦] 會議論文/會議摘要 |
2011-03-27 |
Design and synthesis of potent Aurora kinase inhibitors |
- |
|
[陳志豪] 期刊論文 |
2009-08-01 |
Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors |
- |
|
[謝興邦] 會議論文/會議摘要 |
2013-04 |
Design and synthesis of Aurora kinase inhibitors as anticancer agents |
- |
|
[謝興邦] 會議論文/會議摘要 |
2005-03 |
Design and structure-activity relationships of novel indole-based PPAR agonists as antidiabetic agents |
- |
|
[謝興邦] 期刊論文 |
2009-04-23 |
Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists |
- |
|
[陳志豪] 期刊論文 |
2009-11-01 |
Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors |
- |
|
[謝興邦] 會議論文/會議摘要 |
2005-03 |
Design, synthesis and sar of indole-based PPAR agonists |
- |
|
[謝興邦] 會議論文/會議摘要 |
2012-03-25 |
Design, synthesis, and SAR studies of duel FLT-3 and Aurora kinase inhibitors |
- |
|
[夏克山] 期刊論文 |
2008-02-07 |
Design, synthesis, and biological evaluation of novel alkenylthiophenes as potent and selective CB1 cannabinoid receptor antagonists |
- |
|
[陳志豪] 期刊論文 |
2009-04-01 |
Design, synthesis, and anti-HCV activity of thiourea compounds |
- |
|
[陳炯東] 期刊論文 |
2021-08-01 |
DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity |
- |
|
[陳志豪] 專利 |
2012-03-01 |
C型肝炎病毒抑制劑 |
- |
|
[謝興邦] 專利 |
2011-11-15 |
Coumarin compounds and their use for treating cancer |
- |
|
[李秀珠] 期刊論文 |
2013-06 |
c-Jun-mediated anti-cancer mechanisms of tylophorine |
- |
|
[岳嶽] 期刊論文 |
2013-05 |
Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus |
- |
|
[鄒倫] 期刊論文 |
2021-01 |
BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy |
- |
|
[陳炯東] 會議論文/會議摘要 |
2019-07 |
BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy |
- |
|
[徐祖安] 期刊論文 |
2010-01 |
BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses |
- |
|
[謝興邦] 會議論文/會議摘要 |
2011-09-23 |
BPR1K653, a novel Aurora Kinase Inhibitor, exhibits potent anti-proliferative activity in P-gp170 (MDR1)-mediated VX680-resistant cancer cells in vitro and in vivo |
- |
|
[趙宇生(2002-2013)] 會議論文/會議摘要 |
2012-11 |
BPR1J271, a novel FLT3 inhibitor for treating acute myeloid leukemia |
- |
|
[徐祖安] 期刊論文 |
2012-01 |
BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML |
- |
|
[葉燈光] 期刊論文 |
2013-11 |
BPR0C305, an orally active microtubule-disrupting anticancer agent |
- |
|
[陳炯東] 期刊論文 |
2011-01 |
BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities |
- |
|
[謝興邦] 會議論文/會議摘要 |
2013-04-07 |
BPR000K, a novel Aurora kinase inhibitor |
- |
|
[洪明秀] 期刊論文 |
2010-10 |
Biphasic suppression of appetite by cannabinoid CB1 receptor antagonists with distinct functional activities |
- |
|
[葉燈光] 期刊論文 |
2007-07 |
Biotransformation of 6-methoxy-3-(3 ',4 ',5 '-trimethoxy-benzoyl)-1-hindole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes |
- |
|
[夏克山] 期刊論文 |
2008-09-11 |
Bioisosteric replacement of the pyrazole 5-aryl moiety of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A). A novel series of alkynylthiophenes as potent and selective cannabinoid-1 receptor antagonists |
- |
|
[夏克山] 期刊論文 |
2008-09-21 |
Bioisosteric replacement of the pyrazole 3-carboxamide moiety of rimonabant. A novel series of oxadiazoles as CB1 cannabinoid receptor antagonists |
- |
|
[陳新(2002-2015)] 期刊論文 |
2009-07-15 |
Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor |
- |
|
[徐祖安] 期刊論文 |
2008-05 |
Bioassay-guided purification and identification of PPARa/gamma agonists from Chlorella sorokiniana |
- |
|
[謝興邦] 期刊論文 |
2013-05 |
Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules |
- |
|
[謝興邦] 期刊論文 |
2008-03-01 |
Aurora kinase A inhibitors: Identification, SAR exploration and molecular modeling of 6,7-dihydro-4H-pyrazolo-[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-dione scaffold |
- |
|
[徐祖安] 期刊論文 |
2009-02 |
Aurintricarboxylic acid inhibits influenza virus neuraminidase |
- |
|
[伍素瑩] 期刊論文 |
2008-08 |
A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors |
- |
|
[伍素瑩] 期刊論文 |
2009-06 |
A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitiors [Erratum: European Journal of Medicinal Chemistry. 2008 Aug;43(8):1603-1611.] |
- |
|
[陳志豪] 期刊論文 |
2017-01 |
A potent, selective, and orally bioavailable HCV NS5A inhibitor for treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazo l-2-yl)pyrrolidine-2-carboxamide |
- |
|
[謝興邦] 專利 |
2008-11-25 |
Anti-tumor compounds |
- |
|
[陳炯東] 期刊論文 |
2010-02 |
Antitumor activities and pharmacokinetics of silatecans DB-67 and DB-91 |
- |
|
[謝興邦] 會議論文/會議摘要 |
2007-07 |
Anti-influenza drug discovery |
- |
|
[謝興邦] 期刊論文 |
2010-02-25 |
Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives |
- |
|
[謝興邦] 期刊論文 |
2012-09 |
Anti-influenza drug discovery: Identification of an orally bioavailable quinoline derivative through activity- and property-guided lead optimization |
- |
|
[葉燈光] 專利 |
2013-06-05 |
Anticancer oral formulation |
- |
|
[葉燈光] 專利 |
2014-08-15 |
Anticancer oral formulation |
- |
|
[趙宇生(2002-2013)] 期刊論文 |
2010-07 |
Antiangiogenic Activities and Cisplatin-combined Antitumor Activities of BPR0L075 |
- |
|
[洪明秀] 期刊論文 |
2015-05 |
A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis |
- |
|
[陳志豪] 期刊論文 |
2019-04-01 |
A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus |
- |
|
[謝興邦] 期刊論文 |
2012-12 |
An efficient, mild and scalable synthesis of bioactive compounds containing the angelicin scaffold |
- |
|
[李秀珠] 期刊論文 |
2008-10-15 |
Analogues of 2-phenyl-ethenesulfonic acid phenyl ester have dual functions of inhibiting expression of inducible nitric oxide synthase and activating peroxisome proliferator-activated receptor gamma |
- |
|
[徐祖安] 期刊論文 |
2008-04-01 |
A mammalian cell-based reverse two-hybrid system for functional analysis of 3C viral protease of human enterovirus 71 |
- |
|
[徐祖安] 期刊論文 |
2012-01 |
A High-throughput cell-based screening for L858R/T790M mutant epidermal growth factor receptor inhibitors |
- |
|
[黃嘯谷] 期刊論文 |
2013-06 |
A common environmental pollutant, 4-nonylphenol, promotes allergic lung inflammation in a murine model of asthma |
- |
|
[陳怡榮] 期刊論文 |
2008-06-01 |
A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors |
- |
|
[翁紹華] 期刊論文 |
2018-04 |
4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy |
- |
|
[蔣維棠] 期刊論文 |
2012-06-07 |
3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3) |
- |
|
[謝興邦] 會議論文/會議摘要 |
2013-04-07 |
3D-QSAR assisted drug design: Identification of a potent quinazoline based Aurora kinase inhibitor |
- |
|
[謝興邦] 期刊論文 |
2013-01 |
3D-QSAR-assisted drug design: Identification of a potent quinazoline-based aurora kinase inhibitor |
- |
|
[蔣維棠] 期刊論文 |
2007-03-01 |
3-[2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-butyramide analogues as selective DPP-IV inhibitors for the treatment of type-II diabetes |
- |
|
[蔣維棠] 期刊論文 |
2006-01-12 |
2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,2,3,4-tetrahydroisoquinoline: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV |
- |
|
[陳新(2002-2015)] 期刊論文 |
2010-06-15 |
(2S,4S)-1-[2-(1,1-Dimethyl-3-oxo-3-pyrrolidin-1-yl-propylamino)acetyl]-4-fluoro-pyrrolidine-2-carbonitrile: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV |
- |
|
[伍素瑩] 期刊論文 |
2009-10 |
(1,3-Diphenyl-1H-pyrazol-4-yl)-methylamine analogues as inhibitors of dipeptidyl peptidases |
- |
|